prior authorization

Abstracts

Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network

08/23/2024

Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.

Delays in cancer treatment...

08/23/2024

Journal of Clinical Pathways

Prior Authorization

Read more about Prior Authorization
108 views

Research Reports

Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings

08/07/2023

Kathryn Christensen, MS

Timothy Dollear, MD

Rama Al Ghannam, PharmD

Eric Gratias, MD, FAAP

Robinson Ortiz, MD

Stephen Hamilton, MD

Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.

Kathryn Christensen, MS, and...

08/07/2023

Journal of Clinical Pathways

Research Reports

08/15/2022

Stephen Hamilton, MD

Kathryn Christensen, MS

Margaret Rausa, PharmD

Nick Andrews, PharmD

Timothy Dollear, MS

Christopher Linkimer, CPA

Eric Gratias, MD, FAAP

Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.

Dr Hamilton and colleagues...

08/15/2022

Journal of Clinical Pathways

Interview

Utility of Robotic Process Automation for Prior Authorizations, Pathways

05/13/2020

In a session at the Community Oncology Alliance (COA) Annual Meeting (April 24, 2020), Alti Rahman, MHA, MBA, practice administrator, Oncology Consultants (Houston, TX), and colleagues provided an explanation of the...

In a...

05/13/2020

Journal of Clinical Pathways